Wednesday, September 07, 2022 12:26:26 PM
Psycheceutical is poised to be the leader in this space
"Our mission at Psycheceutical is to develop, improve, and commercialize cutting-edge delivery technologies that can be used across the mental health treatment spectrum while providing safe and effective delivery of psychedelic pharmaceutical medicines."
"Our visionary founders are considered among the top minds in the psychedelic space, embracing the latest technologies to further the advancement of mental health science."
"Our technology is intended to deliver compounds across the blood-brain-barrier while bypassing the GI tract and liver, eliminating hallucinogenic effects and vastly reducing exposure to drug toxicities and side effects.
This long-awaited precision dosing technology is designed to allow for high bioavailability of compounds to target cells, increased cellular uptake, and immediate and sustained symptom relief."
My opinion is just my opinion and not a recommendation to buy or sell anything.
Recent BWVI News
- Form C/A - Offering Statement: [Amend] • Edgar (US Regulatory) • 11/01/2023 09:24:01 PM
- Will Shares of this Psycheceutical Pop on Dosing News? • AllPennyStocks.com • 07/13/2023 02:52:00 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM